Chennai :

Arvind Remedies , a producer of branded and generic pharmaceutical products, has entered into a memorandum of understanding  ( MOU ) with SRM University in Chennai to use the university’s patent to manufacture and market drugs for type II diabetes and coronary heart disease.

These drugs will be manufactured in the form of tablets and will be launched in mid of 2015, first in the domestic market which will be followed by the global market.

“According to the International Diabetes Federation, 382 million people across world have diabetes, which is expected to rise to 592 million by 2035. The number of people with type II diabetes is increasing in every country. In order to curb this disease, we have come up with new drug that is from the botanical source which ensures zero side effects on the health of the patient. We are expecting this new drug to be available in the markets by mid 2015,” Dr B Arvind Shah, managing director and chief executive officer, Arvind Remedies.

“Coronary heart disease is also a common type of heart disease and is killing more than 385,000 people annually. We are happy to share that, we have been successful in developing a new drug, which will help in treatment of coronary heart disease,” Dr Shah added.

source: http://www.timesofindia.indiatimes.com / The Times of India / Home> Business> India Business / by Aparna Ramalingam, TNN / May 31st, 2014